I agree, getting patients onto treatment sooner has to be a good thing. Also Correct me if I'm wrong, but the statistical presentation didn't note that only 6 of the patients spent limited time on the now identified ideal dosage, rather than the full 4-6 months.
I also note that The Chairman and COO will be attending business meetings, this suggests pre-programmed meetings, not just hanging out to meet and greet or answer questions.
Good news, though it's significance may not be obvious to the wider investing community.
Good Luck Everyone.
Ann: PharmAust's Phase 1 Study Data Presented at Major Conference, page-11
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |